or Try an Advanced Search...

    Technical Analysis for VRPX - Virpax Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.50 -3.15% -0.02
    VRPX closed down 3.15 percent on Monday, July 1, 2024, on 23 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical VRPX trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Doji - Bullish? Reversal 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Narrow Range Bar Range Contraction -3.15%
    Inside Day Range Contraction -3.15%
    Wide Bands Range Expansion -3.15%
    Oversold Stochastic Weakness -3.15%
    Narrow Range Bar Range Contraction -3.64%
    Wide Bands Range Expansion -3.64%
    Older End-of-Day Signals for VRPX ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 9 hours ago
    Down 3% about 9 hours ago
    Fell Below Previous Day's Low about 9 hours ago
    Down 2 % about 9 hours ago
    Down 1% about 9 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    VRPX Chart by TradingView
    Basic chart:

    Profile

    Virpax Pharmaceuticals, Inc. Description

    Virpax Pharmaceuticals, Inc. develops and manufactures non-opioid and non-addictive based drug compounds and drug delivery systems for pain management. It offers products, such as Probudur, an injectable bupivacaine hydrogel for postoperative pain management; Epoladerm, a diclofenac metered-dose spray film for acute musculoskeletal pain; and NES100, an endogenous enkephalin intranasal spray for acute and chronic spray. The company develops drug delivery technologies, such as Topical metered-dose spray, Liposomal in Hydrogel encapsulation, and Enkephalin Intranasal spray. It also develops therapies to manage post-traumatic stress disorder (PTSD), as well as to help prevent viral spread, including influenza and SARS-CoV-2 (Covid-19). Virpax Pharmaceuticals, Inc. was founded in 2016 and is based in Malvern, Pennsylvania.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Sciences Drugs Pain Euphoriants Opioids Influenza Pain Management Drug Delivery Analgesics Morphinans Post Traumatic Stress Disorder Drug Delivery Systems Heroin Bupivacaine Morphine Nasal Administration

    Is VRPX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 18 Why Chegg Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
    May 29 Virpax® Pharmaceuticals to Present at 2024 BIO International Convention
    May 15 Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
    May 15 Virpax Announces Pricing of $2.25 Million Public Offering
    May 14 Virpax Pharmaceuticals GAAP EPS of -$2.75
    May 13 Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments
    Apr 30 Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™
    Mar 26 Virpax Pharmaceuticals Reports 2023 Year-End Results
    Feb 7 Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research
    See more VRPX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.4
    52 Week Low 0.4603
    Average Volume 127,421
    200-Day Moving Average 4.05
    50-Day Moving Average 1.41
    20-Day Moving Average 0.63
    10-Day Moving Average 0.54
    Average True Range 0.10
    RSI (14) 27.54
    ADX 36.76
    +DI 14.33
    -DI 33.22
    Chandelier Exit (Long, 3 ATRs) 0.52
    Chandelier Exit (Short, 3 ATRs) 0.77
    Upper Bollinger Bands 0.84
    Lower Bollinger Band 0.42
    Percent B (%b) 0.19
    BandWidth 67.56
    MACD Line -0.24
    MACD Signal Line -0.29
    MACD Histogram 0.0524
    Fundamentals Value
    Market Cap 5.87 Million
    Num Shares 11.7 Million
    EPS -1.17
    Price-to-Earnings (P/E) Ratio -0.43
    Price-to-Sales 0.00
    Price-to-Book 0.67
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.56
    Resistance 3 (R3) 0.56 0.55 0.55
    Resistance 2 (R2) 0.55 0.53 0.55 0.55
    Resistance 1 (R1) 0.52 0.52 0.54 0.52 0.54
    Pivot Point 0.51 0.51 0.51 0.51 0.51
    Support 1 (S1) 0.48 0.49 0.50 0.48 0.46
    Support 2 (S2) 0.47 0.48 0.47 0.45
    Support 3 (S3) 0.44 0.47 0.45
    Support 4 (S4) 0.44